The Clinical Course and Prognosis of Patients With Essential Thrombocythemia Treated With Hydroxyurea and Low-Dose Aspirin in an 11-Year Follow-Up

Mozaffar Aznab, Fareydoon Fathi, Seyed Majid Ahmadi

Abstract


Background: The main objective of this study was to determine the clinical course and prognosis in patients with essential thrombocythemia, treated with hydroxyurea and low-dose aspirin, and complications of treatment in a 12-year follow-up with a precise and regular control.

Methods: In this study, 76 patients with high-risk essential thrombocytosis were retrospectively studied. Data obtained from initial examinations, sonography, complications, and treatment were analyzed.

Results: The mean follow-up was 66.8 months (minimum, 3 months; maximum, 137 months). The mean age of patients was 46.9 years. The mean platelet count of patients at diagnosis and the last follow-up were 818,000/mm3 and 422,000/mm3, respectively. In 60 patients, a gene mutation test for JAK2 V617F was performed and was reported as 36.7% positive. Nine patients had bleeding, two of whom were reported after treatment, and eight cases had thrombosis. Macrocytosis and myelofibrosis were seen in 32 and one cases, respectively. Moreover, no cases of leukemia or malignancy due to cytoreduction therapy were seen. One case of skin lesion was seen.

Conclusion: A rapid diagnosis, accurate and regular control, and timely treatment can improve the quality of life and reduce morbidity and threatening complications. This study showed that complications using aspirin and hydroxyurea treatment are at the minimum level.




J Hematol. 2016;5(4):117-122
doi: https://doi.org/10.14740/jh305w

 


Keywords


Essential thrombocythemia; Hydroxyurea; Low-dose aspirin; Clinical course

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.